SLFN13 and glioblastoma: To date, only limited-to-no data concerning the role of CCRL1, SLFN13, SKI, Cables1, and DCHS1 in GBM are available, and their relation to phenomena known to be associated with the high therapy resistance of the disease, such as dormancy and stemness, are still mainly uncharted.